| Significant risk of graft-versus-host disease with exposure to checkpoint inhibitors before and after allogeneic transplantation A Ijaz, AY Khan, SU Malik, W Faridi, MA Fraz, M Usman, MJ Tariq, S Durer, ... Biology of Blood and Marrow Transplantation 25 (1), 94-99, 2019 | 175 | 2019 |
| Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction MA Fraz, FH Warraich, SU Warraich, MJ Tariq, Z Warraich, AY Khan, ... Critical reviews in oncology/hematology 137, 18-26, 2019 | 24 | 2019 |
| Concomitant use of blinatumomab and donor lymphocyte infusion for mixed-phenotype acute leukemia: a case report with literature review S Durer, C Durer, M Shafqat, IY Comba, S Malik, W Faridi, S Aslam, A Ijaz, ... Immunotherapy 11 (5), 373-378, 2019 | 23 | 2019 |
| Treating diffuse large B cell lymphoma in the very old or frail patients A Kumar, MA Fraz, M Usman, SU Malik, A Ijaz, C Durer, S Durer, MJ Tariq, ... Current treatment options in oncology 19, 1-10, 2018 | 11 | 2018 |
| Revisiting role of vaccinations in donors, transplant recipients, immunocompromised hosts, travelers, and household contacts of stem cell transplant recipients A Majeed, Z Harris, E Brucks, A Hinchman, AA Farooqui, MJ Tariq, ... Biology of Blood and Marrow Transplantation 26 (2), e38-e50, 2020 | 9 | 2020 |
| Novel targeted therapies for chronic lymphocytic leukemia in elderly patients: a systematic review AA Farooqui, A Ashraf, TB Farooq, A Anjum, S ur Rehman, A Akbar, ... Clinical Lymphoma Myeloma and Leukemia 20 (7), e414-e426, 2020 | 8 | 2020 |
| Evidence-based supportive care in multiple myeloma A Qureshi, MJ Tariq, Z Shah, M Abu Zar, S Aslam, A Rafae, M Shafqat, ... Journal of Community Hospital Internal Medicine Perspectives 10 (4), 313-317, 2020 | 5 | 2020 |
| Clinical Response and Tolerability of Selinexor in Acute Myeloid Leukemia and Other Hematologic Malignancies-a Systematic Review MJ Tariq, M Yasir, A Khalid, SN Amin, S Samuel, MJ Khalil, S Aslam, ... Blood 132 (Suppl 1), 5231-5231, 2018 | 5 | 2018 |
| Anxiety due to COVID-19 and impact on patients receiving chemotherapy in an inner-city minority population. MJ Tariq, MU Almani, SAA Sherazi, M Usman, AW Arif, B Yim, S Gupta Journal of Clinical Oncology 38 (29_suppl), 108-108, 2020 | 4 | 2020 |
| Daratumumab-based three drug regimens for high-risk multiple myeloma: A meta-analysis. AA Farooqui, M Tariq, S Nabeel, A Ashraf, Z Ahmed, MS Faisal, ... Journal of Clinical Oncology 38 (15_suppl), e20549-e20549, 2020 | 4 | 2020 |
| Independent predictors of mortality and 5-year trends in mortality and resource utilization in hospitalized patients with diffuse large B cell lymphoma ZH Bodla, M Hashmi, F Niaz, U Farooq, F Khalid, MJ Tariq, MJ Khalil, ... Baylor University Medical Center Proceedings, 1-9, 2023 | 3 | 2023 |
| Prevalence of Major Depression Among Cancer Patients: Single Center Tertiary Care Hospital Experience from Lahore, Pakistan AA Farooqui, M Waqas, A Iftikhar, MJ Tariq, F Anwer Blood, The Journal of the American Society of Hematology 134 (Supplement_1 …, 2019 | 3 | 2019 |
| Efficacy and Toxicity Profile of Elotuzumab for Multiple Myeloma: A Systematic Review and Meta-Analysis F Jamil, M Shafqat, S Samuel, Z Shah, C Durer, S Durer, M Sadiq, ... Blood 132 (Suppl 1), 5640-5640, 2018 | 3 | 2018 |
| Efficacy and Safety of Selinexor for Acute Myeloid Leukemia: A Systematic Review MS Hashmi, MA Sharif, A Jaan, U Salman, S Aziz, A Shahab, Z Ahmed, ... BLOOD 136, 2020 | 2 | 2020 |
| The Comparison of Unmanipulated Bone Marrow Versus Peripheral Blood Haploidentical Stem Cell Transplantation in Adult Acute Leukemia: A Systematic Review and Meta-Analysis S Durer, C Durer, F Jamil, II Selene, MN Malik, A Rafae, MA Zar, A Kamal, ... Blood 132 (Suppl 1), 5768-5768, 2018 | 2 | 2018 |
| Efficacy and Safety of Histone Deacetylase Inhibitors in Multiple Myeloma-a Systematic Review of Early Phase Clinical Trials S Samuel, MJ Tariq, M Usman, A Khalid, MA Fraz, A Ijaz, F Jamil, M Yasir, ... Blood 132 (Suppl 1), 5629-5629, 2018 | 2 | 2018 |
| The Use of Checkpoint Inhibitors before and after Allogeneic Stem Cell Transplantion: A Double-Edged Sword AY Khan, A Ijaz, M Usman, MJ Tariq, MA Fraz, MJ Khalil, C Durer, S Durer, ... Blood 132 (Suppl 1), 5722-5722, 2018 | 2 | 2018 |
| Current Novel Targeted Therapeutic Strategies in Multiple Myeloma CHT Lin, MJ Tariq, F Ullah, A Sannareddy, F Khalid, H Abbas, A Bader, ... International Journal of Molecular Sciences 25 (11), 6192, 2024 | 1 | 2024 |
| Frequency, Histologic, and Prognostic Significance of CD30 Expression in AIDS-associated Diffuse Large B-Cell Lymphoma A Chaudhry, MJ Tariq, E Shah, CE DeMarco, EG Reid, E Cesarman, ... Blood 138 (Supplement 1), 1447-1447, 2021 | 1 | 2021 |
| COVID vaccine acceptance in inner-city minority cancer population. B Yim, K Maklad, SAA Sherazi, MJ Tariq, M Usman, S Gupta Journal of Clinical Oncology 39 (28_suppl), 134-134, 2021 | 1 | 2021 |
Faiz AnwerCleveland Clinic, Taussig Cancer CenterVerified email at ccf.org